IMAX Slashes to $20 Million Global Weekend for “Demon Slayer: Infinity Castle” as Anime Phenomenon Expands to North America
IMAX(NYSE:IMAX) NEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced that “Demon Slayer: Kimetsu No Yaiba Infinity Castle” continued its impressive global rollout with a $20 million weekend worldwide — led by a stunning $13 million opening in North America, representing 19% of the film’s Domestic box office. The strong result marked the biggest IMAX domestic opening ever for a local language release and pushed IMAX to a record $316 million in local language box office for 2025 — far surpass
IMAX To Present at the Bank of America Media, Communications & Entertainment Conference
IMAXNEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced that the Company will participate in the Bank of America Media, Communications & Entertainment Conference. Event: 2025 Bank of America Media, Communications & Entertainment Conference Location: New York, NY Fireside Date: Wednesday, September 3rd Virtual Fireside Time: 8:50 a.m. ET IMAX Executive: Rich Gelfond, CEO In addition, IMAX will participate in one-on-one investor meetings at the conference. A live webcast
Apple Cinemas and IMAX Expand Partnership with Agreement for Five New and Upgraded IMAX with Laser Locations Across U.S.
IMAXNEW YORK--(BUSINESS WIRE)--Apple Cinemas and IMAX® Corporation (NYSE: IMAX) today announced an agreement for five IMAX with Laser systems in the United States — doubling the current IMAX footprint in Apple Cinemas locations. Under the agreement, IMAX will return to Philadelphia for the first time since 2020 in Apple Cinemas forthcoming Riverview Plaza – a renovation to the city’s highest-grossing multiplex before it closed in 2020 that will reopen as the largest cinema in the Center City downto
IMAX Announces $100M Increase To Its Current Share Repurchase Program
IMAXIMAX Announces $100 Million Increase to Current Share-Repurchase Program
IMAXNEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced an increase of $100 million in the Company’s share repurchase program along with a one-year extension through June 30, 2027. This expansion brings the Company’s total share repurchase authorization to $500 million, of which approximately $250 million remains available. The Company has repurchased a total of 15.1 million of its common shares (or approximately a 23% net reduction in shares outstanding) for an aggregate purch
IMAX Announces $100 Million Increase to Current Share-Repurchase Program
IMAXNEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) today announced an increase of $100 million in the Company’s share repurchase program along with a one-year extension through June 30, 2027. This expansion brings the Company’s total share repurchase authorization to $500 million, of which approximately $250 million remains available. The Company has repurchased a total of 15.1 million of its common shares (or approximately a 23% net reduction in shares outstanding) for an aggregate purch
Macquarie Maintains Outperform on Imax, Raises Price Target to $32
IMAXWells Fargo Maintains Overweight on Imax, Lowers Price Target to $30
IMAXBarrington Research Maintains Outperform on Imax, Maintains $32 Price Target
IMAXRosenblatt Maintains Buy on Imax, Maintains $35 Price Target
IMAXImax Q1 Adj. EPS $0.13 Misses $0.16 Estimate, Sales $86.70M Beat $84.22M Estimate
IMAXAn Overview of Imax's Earnings
IMAXJP Morgan Maintains Neutral on Imax, Lowers Price Target to $26
IMAXStrong Slate, Premium Push Fuel IMAX Forecast Upgrades, Says Analyst
IMAXIMAX Corporation (NYSE:IMAX) received a reiterated Buy rating and $35 price target from Rosenblatt, citing a blowout Q1 box office of $280 million, well above projections. The success of Ne Zha 2 drove $162.6M for IMAX. Despite China trade concerns, no official restrictions surfaced. The company remains well-positioned with strong local content, expanding partnerships, and a blockbuster-packed 2025–2026 film slate.
Benchmark Reiterates Buy on Imax, Maintains $30 Price Target
IMAXJP Morgan Maintains Neutral on Imax, Raises Price Target to $27
IMAXImax China Roars Into Year Of The Snake After Weak Performance In 2024
IMAXAnimated blockbuster "Ne Zha 2," brings much-needed boost to IMAX China, after a gloomy 2024.
Macquarie Maintains Outperform on Imax, Raises Price Target to $30
IMAXBarrington Research Maintains Outperform on Imax, Raises Price Target to $32
IMAXBenchmark Reiterates Buy on Imax, Maintains $30 Price Target
IMAXWells Fargo Maintains Overweight on Imax, Raises Price Target to $32
IMAXRosenblatt Maintains Buy on Imax, Raises Price Target to $35
IMAXImax Q4 Adj EPS $0.27 Misses $0.30 Estimate, Sales $92.67M Miss $104.08M Estimate
IMAXBenchmark Reiterates Buy on Imax, Maintains $30 Price Target
IMAXBenchmark Reiterates Buy on Imax, Maintains $30 Price Target
IMAXBarrington Research Maintains Outperform on Imax, Raises Price Target to $28
IMAXRoth MKM Maintains Buy on Imax, Raises Price Target to $28
IMAXBarrington Research Maintains Outperform on Imax, Maintains $24 Price Target
IMAXRosenblatt Maintains Buy on Imax, Maintains $28 Price Target
IMAXMKM Partners Maintains Buy on Imax, Lowers Price Target to $23
IMAXImax Q1 Adj. EPS $(0.11) Misses $(0.04) Estimate, Sales $60.00M Beat $59.13M Estimate
IMAX